Journal of Neurology

Article	Citations
Maximilian Schäfer (1852 − 1923)	192
Comparative analysis of clinical and imaging data between patients with myelin oligodendrocyte glycoprotein antibody disease and patients with aquaporin 4 antibody-positive neuromyelitis optica spectr	148
Neuropsychological and neuroimaging characteristics of classical superficial siderosis	117
A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing–remitting multiple sclerosis	106
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies	103
The resilience of the inner ear—vestibular and audiometric impact of transmastoid semicircular canal plugging	94
Adaptive deep brain stimulation for Parkinson’s disease: looking back at the past decade on motor outcomes	85
Sleep disturbances associated with DPPX autoantibodies: a case series	83
Frequency of demyelinating disease activity following immune checkpoint inhibitor cancer immunotherapy	82
Age-dependent perturbation of the perceptual and postural vertical by visual roll vection and susceptibility to motion sickness in children	81
Managing blood pressure in acute cerebral infarction	81
Advances in the genetics of stroke risk and recovery	80
Novel PNPLA8 variants associated with primary ovarian insufficiency, tremors, cerebellar ataxia and limb weakness: a case report and literature review	76
Evidence-based recommendations for the prophylactic use of antiseizure medications (ASMs) in neurosurgery: a systematic review of guidelines	75
Magnetic resonance imaging-based biomarkers of multiple sclerosis and neuromyelitis optica spectrum disorder: a systematic review and meta-analysis	73
Anticoagulation in intracranial haemorrhage with atrial fibrillation	68
CIDP-like autoimmune nodopathy complicated with focal segmental glomerulosclerosis: a case study and literature review	65
Clinical trials for cerebellar ataxia	64
Amyotrophic lateral sclerosis: an update on treatments from clinical trials	63
In memoriam: Prof. Dr. John H. J. Wokke (1952–2022)	61
Clinical characteristics and treatment approaches in patients with Susac syndrome: a scoping review of cases	60
Hereditary transthyretin amyloidosis: a myriad of factors that influence phenotypic variability	56
International survey on the implementation of the European and American guidelines on disorders of consciousness	56
Weaning and extubation failure in myasthenic crisis: a multicenter analysis	55
Virtual reality balance training to improve balance and mobility in Parkinson’s disease: a systematic review and meta-analysis	54

Structural MRI substrate of long-duration response to levodopa in Parkinson’s disease: an exploratory study	52
Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies	51
Feasibility and effects of cognitive training on cognition and psychosocial function in Huntington’s disease: a randomised pilot trial	50
Total functioning capacity scale in Huntington's disease: natural course over time	45
An audit on the assessment and management of osteoporosis in a Parkinson’s and related diseases clinic in Australia	45
Soma and neurite density abnormalities of paramagnetic rim lesions and core-sign lesions in multiple sclerosis	45
Correction: Evolving management of Alzheimer’s disease	44
Incidence of Guillain–Barré syndrome in Cuba before and during the Oropouche virus emergency, 2018–2024	44
Parallel EEG-fNIRS assessments of covert cognition in behaviorally non-responsive ICU patients: A multi-task feasibility study in a case of acute motor sensory axonal neuropathy	44
Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson’s disease: a systematic review and meta-analysis	43
Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study	43
Predictors of drooling severity in people with Parkinson’s disease	43
Generalized epileptic discharges leading into focal onset seizure: GOFE seizures as the initial diagnosis of epilepsy	43
Structural and functional alterations in the brain gray matter among Tourette syndrome patients: a multimodal meta-analysis of fMRI and VBM studies	43
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update	42
A role for the Epstein–Barr virus in multiple sclerosis aetiology?	42
Identification of hub proteins in cerebrospinal fluid as potential biomarkers of Alzheimer’s disease by integrated bioinformatics	42
Identifying the mediating role of inflammation on the relationship between socioeconomic status and Alzheimer’s disease: a Mendelian randomization analysis and mediation analysis	42
Imaging-based outcome prediction in posterior circulation stroke	42
Evaluation of a self-administered iPad®-based processing speed assessment for people with multiple sclerosis in a clinical routine setting	40
Monoallelic KIF1A-related disorders: a multicenter cross sectional study and systematic literature review	40
Sex-specific differences in presentations and determinants of outcomes after endovascular thrombectomy for large vessel occlusion stroke	40
Exploring the predictors of financial impairment in Huntington’s disease using the Enroll-HD dataset	40
In vivo characterization of microglia and myelin relation in multiple sclerosis by combined 11C-PBR28 PET and synthetic MRI	39
Acute carotid stenting versus non-stenting treatment of acute ischemic stroke due to tandem lesions: a systematic review and meta-analysis	38
Clinical and pathological aspects of toxic myopathies	38
Correction to: Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initia	38
Characterisation and differential diagnosis of neurological complications in adults with phenylketonuria: literature review and expert opinion	37
Physical fitness moderates the association between brain network impairment and both motor function and cognition in progressive multiple sclerosis	37
The natural history of primary progressive aphasia: beyond aphasia	37
Retrospective observational study on the use of acetyl-l-carnitine in ALS	37
Conceptual design of a biped-wheeled wearable machine for ALS patients	37
Diagnostic value of neurofilaments in differentiating motor neuron disease from multifocal motor neuropathy	37
Update on recent advances in amyotrophic lateral sclerosis	36
Factors associated with migraine aura-like symptoms in acute ischemic stroke	36
Correction to: Visuospatial working memory in behavioural variant frontotemporal dementia: a comparative analysis with Alzheimer's disease using the box task	35
Addition of the FTD Module to the Neuropsychiatric Inventory improves classification of frontotemporal dementia spectrum disorders	35
Bevacizumab in real-life patients with recurrent glioblastoma: benefit or futility?	34
Supporting brain health in multiple sclerosis: exploring the potential of neuroeducation combined with practical mindfulness exercises in the management of neuropsychological symptoms	34
Acute vestibular syndrome: is skew deviation a central sign?	33
The phenotypic spectrum of KCNT1: a new family with variable epilepsy syndromes including mild focal epilepsy	33
Risk of intracranial haemorrhage and ischaemic stroke after convexity subarachnoid haemorrhage in cerebral amyloid angiopathy: international individual patient data pooled analysis	33
Radiation-induced intracranial vasculitis on high-resolution vessel wall MRI	33
Covid-19 and Parkinson’s disease: an overview	33
Implementation of a 7T Epilepsy Task Force consensus imaging protocol for routine presurgical epilepsy work-up: effect on diagnostic yield and lesion delineation	33
Hypermetabolism associated with worse prognosis of amyotrophic lateral sclerosis	33
Elderly onset neuromyelitis optica spectrum disorder: a case report	33
Evaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis	33
Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies: a large international cohort	32
Brain network topology and future development of freezing of gait in Parkinson’s disease: a longitudinal study	31

Does visuospatial motion perception correlate with coexisting movement disorders in Parkinson’s disease?	31
Hyperactive and cross-coupled head impulse signs in recurrent strokes: clinical signs of global cerebellar dysfunction	30
Presymptomatic grey matter alterations in ALS kindreds: a computational neuroimaging study of asymptomatic C9orf72 and SOD1 mutation carriers	30
Correction to: Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review	30
Increased aneurysm wall permeability colocalized with low wall shear stress in unruptured saccular intracranial aneurysm	29
Oculomotor abnormalities indicate early executive dysfunction in prodromal X-linked dystonia-parkinsonism (XDP)	29
Safety and outcomes of endovascular treatment in patients with very severe acute ischemic stroke	29
Correction to: Monoallelic KIF1A-related disorders: a multicenter cross sectional study and systematic literature review	29
The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experience	29
Correction to: Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing–remitting multiple sclerosis patients	29
Punctuate hippocampal lesions presenting with acute vestibular syndrome	29
Sensory neuropathy due to RFC1 in a patient with ALS: more than a coincidence?	28
Brain structural abnormalities in the preclinical stage of Machado–Joseph disease/spinocerebellar ataxia type 3 (MJD/SCA3): evaluation by MRI morphometry, diffusion tensor imaging and neurite orientat	28
Morphological and molecular comparison of HIV-associated and sporadic inclusion body myositis	28
Effectiveness and safety of rituximab in autoimmune nodopathy: a single-center cohort study	28
Bilateral vestibulopathy patients’ perspectives on vestibular implant treatment: a qualitative study	28
TS-HDS autoantibody: clinical characterization and utility from real-world tertiary care center experience	27
Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study	27
Encephalopathy as a prognostic factor in adults with acute disseminated encephalomyelitis following COVID-19	27
Neural correlates of dual-task walking in people with central neurological disorders: a systematic review	27
Recent advances in novel mutation genes of Parkinson's disease	27
Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis	26
Functional connectivity modifications in monoaminergic circuits occur in fatigued MS patients treated with fampridine and amantadine	26
Clinical features and maternal and fetal outcomes in women with Guillain-Barré syndrome in pregnancy	26
Elevated glutamate and decreased glutamine levels in the cerebrospinal fluid of patients with MELAS syndrome	26
Feasibility of detecting atrophy relevant for disability and cognition in multiple sclerosis using 3D-FLAIR	26
Acute pediatric encephalitis: etiology, course, and outcome of a 12-year single-center immunocompetent cohort	26
Combined genotype of HCRTR2 and CLOCK variants in a large family of cluster headache with familial periodicity phenotype	26
The rising role of cognitive reserve and associated compensatory brain networks in spinocerebellar ataxia type 2	26
Reclassification of patients with tremor syndrome and comparisons of essential tremor and essential tremor-plus patients	26
Premorbid frailty predicts short- and long-term outcomes of reperfusion treatment in acute stroke	26
Predictors of acute ischemic cerebral lesions in immune-mediated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome	26
Clinical features and recovery pattern of secondary hypokalaemic paralysis	25
Presymptomatic geographical distribution of ALS patients suggests the involvement of environmental factors in the disease pathogenesis	25
Decline in the number of patients with meningitis in German hospitals during the COVID-19 pandemic	25
Epileptic disorders in Becker and Duchenne muscular dystrophies: a systematic review and meta-analysis	25
Reversible cerebral vasoconstriction syndrome after intravenous iron substitution: a case report	25
Seed amplification assay results illustrate discrepancy in Parkinson’s disease clinical diagnostic accuracy and error rates	25
Correction to: Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study	25
Herpetic encephalitis: which treatment for which body weight?	25
Disability in cerebellar ataxia syndromes is linked to cortical degeneration	25
Two-year longitudinal follow-up of visual illusions and hallucinations in Parkinson’s disease	25
Domain-specific neuropsychological investigation of CAA with and without intracerebral haemorrhage	24
Concurrence of seizures and peri-ictal delirium in the critically ill - its frequency, associated characteristics, and outcomes	24
Correction to: Mechanical thrombectomy does not increase the risk of acute symptomatic seizures in patients with an ischaemic stroke: a propensity score matching study	24
Genotypes and phenotypes of motor neuron disease: an update of the genetic landscape in Scotland	24
Determinant of the cerebellar cognitive affective syndrome in Friedreich’s ataxia	24
Discordant vestibulo-ocular reflex function according to the frequency and mode of stimulation	24
Direction and magnitude of displacement differ between slowly expanding and non-expanding multiple sclerosis lesions as compared to small vessel disease	24
Unveiling the invisible: a qualitative interview study on the impact of young onset Parkinson’s disease on (ex-)partners	24
Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim resu	24
Non-invasive perfusion territory quantification and time-resolved angiography by arterial spin labeling in a patient with a large right-hemispheric AVM: case report	24
Cerebral venous sinus thrombosis in the setting of COVID-19 vaccination: a systematic review and meta-analysis	24
Seasonal variation and temporal relationship to the COVID-19 pandemic of NMDA receptor antibody results	24
Contraversive saccadic hypermetria and ipsilateral limb ataxia: the brachium conjunctivum syndrome	24
An MRI evaluation of white matter involvement in paradigmatic forms of spastic ataxia: results from the multi-center PROSPAX study	24
An observational cohort study on pulmonary function in adult patients with 5q-spinal muscular atrophy under nusinersen therapy	23
Correction to: Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis	23
Natalizumab continuation versus switching to ocrelizumab after PML risk stratification in RRMS patients: a natural experiment	23
Long-term outcome after decompressive hemicraniectomy for malignant middle cerebral artery infarction	23
Digital outcome measures are associated with brain atrophy in patients with multiple sclerosis	23
Transcranial direct current stimulation enhances motor learning in Parkinson’s disease: a randomized controlled trial	23
Hippocampal hub failure is linked to long-term memory impairment in anti-NMDA-receptor encephalitis: insights from structural connectome graph theoretical network analysis	23
Functional movement disorders triggered by reality shifting and the Backrooms—another social media traps	23
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells	23
Glymphatic function from diffusion-tensor MRI to predict conversion from mild cognitive impairment to dementia in Parkinson’s disease	23
RNA interference in late-stage hereditary transthyretin amyloidosis: a clinicopathological study	22
Rasmussen’s encephalitis: structural, functional, and clinical correlates of contralesional epileptiform activity	22
Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis	22
Explaining recovery from coma with multimodal neuroimaging	22
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension	22
Clinical spreading of muscle weakness in amyotrophic lateral sclerosis (ALS): a study in 910 patients	22
Correction to: Factors associated with migraine aura-like symptoms in acute ischemic stroke	22
Acetyl-DL-leucine in combination with memantine improves acquired pendular nystagmus caused by multiple sclerosis: a case report	22
Multiple sclerosis optic neuritis and trans-synaptic pathology on cortical thinning in people with multiple sclerosis	22
Complications of reversible cerebral vasoconstriction syndrome in relation to age	22
Endovascular thrombectomy versus medical management for moderate-to-severe anterior cerebral artery occlusion stroke	21
Richard Gundry Rows (1866–1925)	21
Thrombospondin-4 as potential cerebrospinal fluid biomarker for therapy response in pediatric spinal muscular atrophy	21
Henry J.M. Barnett (1922–2016)	21

Neuromyelitis optica spectrum disorder with a familial Mediterranean fever gene E84K mutation	21
Does repetitive transcranial magnetic stimulation have a beneficial effect on improving unilateral spatial neglect caused by stroke? A meta-analysis	21
A multidimensional gender analysis of health technology self-efficacy among people with Parkinson’s disease	21
Thalamic ventral-Oralis complex/rostral zona incerta deep brain stimulation for midline tremor	21
Automated algorithms for seizure forecast: a systematic review and meta-analysis	21
Factors affecting the diagnostic delay of myasthenia gravis	20
Genetic and functional analyses of SPTLC1 in juvenile amyotrophic lateral sclerosis	20
Clinical characteristics of overlapping syndrome in patients with GFAP-IgG and MOG-IgG: a case series of 8 patients and literature review	20
Definition and diagnosis of Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology	20
Autonomic nervous system dysfunction in idiopathic REM sleep behavior disorder as a short-term risk for a synucleinopathy	20
Interpretable deep learning survival predictions in sporadic Creutzfeldt–Jakob disease	20
Short-read genome sequencing allows ‘en route’ diagnosis of patients with atypical Friedreich ataxia	20
18F-DPA714 PET/MRI as a potential imaging tool for detecting possible antibody-negative autoimmune encephalitis: a prospective study	20
Correction to: Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort	20
Exploring habenular structural connectivity in Parkinson's disease: insights from 7 T MRI study	20
Association between blood-based protein biomarkers and brain MRI in the Alzheimer’s disease continuum: a systematic review	20
Correction: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study	20
How to distinguish spinocerebellar ataxia 27B from late onset cerebellar ataxia: insights from a case–control study	19
Randomized phase 2 study of perampanel for sporadic amyotrophic lateral sclerosis	19
Pooled analysis of patients with inherited prion disease caused by two- to twelve-octapeptide repeat insertions in the prion protein gene (PRNP)	19
Clinical diagnosis sensitivity of neuropathologically established multiple system atrophy in Japan	19
Endovascular treatment of ischemic stroke due to isolated internal carotid artery occlusion: ETIS registry data analysis	19
Tacrolimus-induced Parkinsonism	19
Gastric emptying time and its correlation with cardiac MIBG in body-first and brain-first subtype Parkinson’s disease	19
Neuropsychological profile of French adults with early-treated phenylketonuria: a multicenter study	19
Impairment of oculomotor functions in patients with early to advanced amyotrophic lateral sclerosis	19
Disability worsening outcome in multiple sclerosis based on EDSS: does half a point matter?	19
Different patterns of acute saccadic response to levodopa in de novo Parkinson’s disease	19
Correction to: Synergistic effects of vagus nerve stimulation and antiseizure medication	19
Alemtuzumab induces severe orbitopathy in relapsing–remitting multiple sclerosis	19
Correction to: Predicting neurologic recovery after severe acute brain injury using resting-state networks	18
Autonomic dysfunction in long-COVID syndrome: a neurophysiological and neurosonology study	18
Neurological manifestation of HEV infection: still a rare disease entity?	18
The value of routine blood work-up in clinical stratification and prognosis of patients with amyotrophic lateral sclerosis	18
Novel ultrasound neuromodulation therapy with transcranial pulse stimulation (TPS) in Parkinson’s disease: a first retrospective analysis	18
Relationships between intracranial arterial dolichoectasia and small vessel disease in patients with ischaemic stroke: a systematic review and meta-analysis	18
Blood pressure variability predicts poor outcomes in acute stroke patients without thrombolysis: a systematic review and meta-analysis	18
Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy	18
Phenotype-driven reanalysis reveals five novel pathogenic variants in 40 exome-negative families with Charcot–Marie–Tooth Disease	18
Circulating cell-free mtDNA release is associated with the activation of cGAS-STING pathway and inflammation in mitochondrial diseases	18
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod	18
Eye tracking identifies biomarkers in α-synucleinopathies versus progressive supranuclear palsy	18
Long-term safety and efficacy of cipaglucosidase alfa plus miglustat in individuals living with Pompe disease: an open-label phase I/II study (ATB200-02)	18
Acute symptomatic seizures and hippocampal sclerosis: the major contributor for post-stroke epilepsy?	18
Repeated erythema and pain in the lateral thoracic region due to spinal cord infarction: a case report	18
DCTN1 mutation associated parkinsonism: case series of three new families with perry syndrome	18
The efficacy of a directed rhythmic-melodic voice training in the treatment of chronic non-fluent aphasia—Behavioral and imaging results	18
Longitudinal predictors of health-related quality of life in isolated dystonia	18
Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report	18
Investigating the relationship between mild traumatic brain injury and Alzheimer’s disease and related dementias: a systematic review	18
DNA hypermethylation of NOTCH2NLC in neuronal intranuclear inclusion disease: a case–control study	18
Attention impairment in motor functional neurological disorders: a neuropsychological study	18
Evidence for cognitive impairment in patients with vestibular disorders	18
Acute serum free thiols: a potentially modifiable biomarker of oxidative stress following traumatic brain injury	18
Correction to: Late‑onset Huntington’s disease associated with CAG repeat lengths of 30 and 31	17
SARA captures disparate progression and responsiveness in spinocerebellar ataxias	17
Parkinson’s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study	17
The DeMyers: Marian (1922–2012) and William (1924–2008)	17
Respiratory comorbidities and treatments in Duchenne muscular dystrophy: impact on life expectancy and causes of death	17
Correction to: Neurological update: non-motor symptoms in atypical parkinsonian syndromes	17
Neurological update: the palliative care landscape for atypical parkinsonian syndromes	17
Recurrent cerebrovascular events after recent small subcortical infarction	17
The various forms of hereditary motor neuron disorders and their historical descriptions	17
Pallidal deep brain stimulation for patients with myoclonus-dystonia without SGCE mutations	17
Reduced eye gaze fixation during emotion recognition among patients with temporal lobe epilepsy	17
The chronic use of serotonin norepinephrine reuptake inhibitors facilitates dyskinesia priming in early Parkinson’s disease	17
Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis	17
Cerebellopontine angle tumor presenting as vertical strabismus: differentiation of trochlear nerve palsy and skew deviation	17
Use of hip- versus wrist-based actigraphy for assessing functional decline and disease progression in patients with motor neuron disease	17
Correction to: Communicating the relevance of neurodegeneration and brain atrophy to multiple sclerosis patients: patient, provider and researcher perspectives	17
Incidence and risk factors of epilepsy following brain arteriovenous malformation rupture in adult patients	17
Sidney Ochs (1924–2014)	17
Neurological and cognitive sequelae of Covid-19: a four month follow-up	17
Diverse faces of GNAO1: mild forms in epilepsy and autism	17
Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a	16
New remote cerebral microbleeds in acute ischemic stroke: an analysis of the randomized, placebo-controlled WAKE-UP trial	16
Risk and cause of death in post-traumatic epilepsy: a register-based retrospective cohort study	16
Cognitive impairment in psoriasis patients: a systematic review of case–control studies	16
Correction to: Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP‑mediated disease reveals characteristic features useful for diagnosis	16
Microembolic signals and antiplatelet therapy in Moyamoya angiopathy	16
Redefinition of dementia care in Italy in the era of amyloid-lowering agents for the treatment of Alzheimer’s disease: an expert opinion and practical guideline	16
Multisensory hallucinations and other unusual sensory experiences in the context of migraine: a systematic review	16
Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series	16
Impact of multiple treatment cycles with anti-CGRP monoclonal antibodies on migraine course: focus on discontinuation periods. Insights from the multicenter, prospective, I-GRAINE study	16
Hippocampal sclerosis is associated with celiac disease type immunity in patients with drug-resistant temporal lobe epilepsy	16
Recent applications of quantitative electroencephalography in adult intensive care units: a comprehensive review	16
Falsely reassuring impedance in a patient with deep brain stimulation: a case report	16
Psychological impact of COVID-19 containment on CADASIL patients	16
MOG-IgG testing strategies in accordance with the 2023 MOGAD criteria: a clinical-laboratory assessment	16
Neuropathy in ARSACS is demyelinating but without typical nerve enlargement in nerve ultrasound	16
Neurophysiological brain function predicts response to cognitive rehabilitation and mindfulness in multiple sclerosis: a randomized trial	16
Thrombolysis in Stroke-Heart Syndrome: a useful tool for neurocardiac wellness?	16
Progression rate of radiation-induced carotid stenosis in head and neck cancer survivors after statin treatment: a retrospective cohort study	16
Daytime sleepiness might increase the risk of ALS: a 2-sample Mendelian randomization study	15
Adult occipital lobe epilepsy: 12-years on	15